Cargando…
Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease
BACKGROUND: Reliable identification and quantitation of intestinal fibrosis in the setting of co-existing inflammation due to Crohn’s disease (CD) is difficult. We aimed to identify serum biomarkers which distinguish inflammatory from fibrostenotic phenotypes of CD using serum glycoproteome profiles...
Autores principales: | Stidham, Ryan W., Wu, Jing, Shi, Jiaqi, Lubman, David M., Higgins, Peter D. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256928/ https://www.ncbi.nlm.nih.gov/pubmed/28114331 http://dx.doi.org/10.1371/journal.pone.0170506 |
Ejemplares similares
-
The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease
por: Hayashi, Yuki, et al.
Publicado: (2022) -
Ultrasonographic Evaluation of Intestinal Fibrosis and Inflammation in Crohn’s Disease. The State of the Art
por: Ferretti, Francesca, et al.
Publicado: (2021) -
Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn’s disease
por: Newman, Kira L., et al.
Publicado: (2023) -
Serum Glycoproteomic Alterations in Patients with Diabetic Retinopathy
por: Sharma, Ashok, et al.
Publicado: (2020) -
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables
por: Gabriele, Caterina, et al.
Publicado: (2023)